Identification of Novel and Recurrent Disease-Causing Mutations in Retinal Dystrophies Using Whole Exome Sequencing (WES): Benefits and Limitations
Table 1
Clinical phenotypes of patient, variant descriptions and pathogenicity prediction of the variants identified in this study.